Evaluation of MAGE-D4 expression in hepatocellular carcinoma in Japanese patients.
about
Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinomaNovel hepatocellular carcinoma molecules with prognostic and therapeutic potentialsSuppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.High expression and frequently humoral immune response of melanoma-associated antigen D4 in gliomaOverexpression of MAGE-D4 in colorectal cancer is a potentially prognostic biomarker and immunotherapy targetNovel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach.NRAGE promotes the malignant phenotype of hepatocellular carcinoma.Detection of serum melanoma-associated antigen D4 in patients with squamous cell carcinoma of the esophagus.Clinical significance of expression and epigenetic profiling of TUSC1 in gastric cancer.An integrated multigene expression panel to predict long-term survival after curative hepatectomy in patients with hepatocellular carcinoma.Aberrant expression of melanoma-associated antigen-D2 serves as a prognostic indicator of hepatocellular carcinoma outcome following curative hepatectomy.Prognostic and clinicopathological value of melanoma-associated antigen D4 in patients with glioma.The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.Reduced Expression of Adherens Junctions Associated Protein 1 Predicts Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy.
P2860
Q26784412-5C7DCE3F-F64D-4D01-9737-C4936F2F1D86Q26824909-295DB468-7396-4D24-94FA-BD0704F52FFAQ30009202-C6C5F7FE-4FBA-4C75-AF9E-FB1525FBC66AQ33802891-B118DA2B-4F18-4D34-A86E-297E1A78F2D2Q34029028-D0D7261B-E11F-41E5-921E-DD88A1810365Q35594611-1CE4DF6E-DFF5-46B0-92D1-03AFA53AC3CDQ36640154-0DAB40B4-F7C4-4D88-9DAD-A7D6D352C8A9Q38878023-C2FCFB6F-C8EC-4888-AA1D-BCE826366904Q39008026-B20B298F-31F7-4595-8BEB-F83782234631Q42378505-894A9743-A88E-4A11-B67B-85EFA07B878EQ43128688-6263989D-D00C-4F6E-A2E6-E02B0ED14881Q52655180-C4ED377B-AAD2-4D4F-A5C5-01138EBF5245Q53588322-AC5B63FC-ECF2-4E0F-8484-33A5CB02F0E4Q54158231-E6D3A813-82AE-4DB6-A255-A980453482AA
P2860
Evaluation of MAGE-D4 expression in hepatocellular carcinoma in Japanese patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Evaluation of MAGE-D4 expression in hepatocellular carcinoma in Japanese patients.
@en
Evaluation of MAGE-D4 expression in hepatocellular carcinoma in Japanese patients.
@nl
type
label
Evaluation of MAGE-D4 expression in hepatocellular carcinoma in Japanese patients.
@en
Evaluation of MAGE-D4 expression in hepatocellular carcinoma in Japanese patients.
@nl
prefLabel
Evaluation of MAGE-D4 expression in hepatocellular carcinoma in Japanese patients.
@en
Evaluation of MAGE-D4 expression in hepatocellular carcinoma in Japanese patients.
@nl
P2093
P2860
P356
P1476
Evaluation of MAGE-D4 expression in hepatocellular carcinoma in Japanese patients.
@en
P2093
Hideki Takami
Hiroyuki Sugimoto
Hisaharu Oya
Masaya Suenaga
Mikako Asai
Mitsuro Kanda
Shuji Nomoto
Soki Hibino
Suguru Yamada
Tsutomu Fujii
P2860
P304
P356
10.1002/JSO.23440
P577
2013-09-20T00:00:00Z